Recent identification of genetic variants linked to enhanced risk in sporadic AD onset through genome-wide association studies (GWAS) implicate numerous risk genes which feature enriched expression in microglia, including TREM2 and CD33 [9, 22, 25, 34, 50]. Here, TREM2 is linked to Alzheimer disease.